Skip to main content

Specialty Pharmacy

  • Kroger announces merger with specialty pharmacy Axium Pharmacy

    CINCINNATI — Kroger on Thursday announced it will acquire the outstanding shares of Axium Pharmacy Holdings, a leading specialty pharmacy, and merge the two companies.

    The partnership gives Kroger significantly enhanced capabilities to serve customers who require complex drug therapies, and to deliver those therapies at a greater value to customers and insurance payers, the grocer stated. Financial terms were not disclosed.

  • CSPN, Dara BioSciences enter distribution contract for breast cancer drug

    DREXEL HILL, Pa. — The Community Specialty Pharmacy Network has entered a contract with Dara BioSciences to distribute a nonsteroidal anti-estrogen product.

    CSPN announced the agreement with Dara to distribute Soltamox (tamoxifen) solution for oral administration. The drug, a treatment for breast cancer, is for patients who have difficulty swallowing pills.

  • Abbott drug shows improvement in young adults with arthritis

    ABBOTT PARK, Ill. — Patients with a form of arthritis that affects young adults taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results.

    Abbott announced Monday the first long-term patient-reported health outcomes data for the phase-3 "ABILITY-1" trial of Humira (adalimumab) in patients with nonradiographic axial spondyloarthritis, or nr-axSpA. Results of the trial were presented at the American College of Rheumatology's annual scientific meeting in Washington.

  • FDA approves new strength of HIV drug

    TITUSVILLE, N.J. — The Food and Drug Administration has approved a new strength of a drug for HIV made by Johnson & Johnson, the drug maker said.

    J&J subsidiary Janssen Therapeutics announced the approval of an 800-mg formulation of Prezista (darunavir) as a once-daily treatment for HIV. The drug is designed to be taken with food at the same time as ritonavir and in combination with other HIV drugs.

  • BI launches hepatitis C website

    RIDGEFIELD, Conn. — Drug maker Boehringer Ingelheim has created a website designed for patients with hepatitis C and advocates, the company said Friday.

    BI announced the launch of HepCRedefined.com, which it describes as an online portal to help improve the lives of those living with the virus through education, information and understanding.

  • Diplomat Specialty Pharmacy to hire 100 new employees

    FLINT, Mich. — A rapidly growing specialty pharmacy company in Michigan is about to experience another spurt.

    Diplomat Specialty Pharmacy said it had an immediate need to fill 100 full-time jobs, primarily in patient care coordination, order entry and customer service, but including 10 to 15 positions in areas like nursing, five in sales and account management, and 10 to 15 in technology areas like programming, quality analysis, data modeling and data architecture.

  • FDA panel recommends approval for Novartis Cushing's disease drug

    EAST HANOVER, N.J. — A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

  • FDA approves Pfizer rheumatoid arthritis drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for rheumatoid arthritis ahead of the day the agency was scheduled to decide whether or not to approve it, the agency said Tuesday.

X
This ad will auto-close in 10 seconds